BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Topics
» Endocrine/metabolic, BioWorld Science
Endocrine/metabolic, BioWorld Science
RSS
NN-42-1007: First potent and selective hepatic glycogen phosphorylase inhibitor
June 7, 1996
Sanguine's PHER-02 development
June 7, 1996
Amgen initiates first leptin clinical study
June 7, 1996
NO-1886 in phase II clinical trials
June 7, 1996
Sankyo discovers ACAT inhibitor
June 7, 1996
Hoescht reports imidobisphosphonic acid derivatives
June 7, 1996
Fujisawa claims ACAT inhibitors
June 7, 1996
Completion of phase I clinical trials on human red blood cell substitute
May 31, 1996
Celtrix announces the initiation of two phase I trials of SomatoKine
May 31, 1996
ACAT inhibitors from Warner-Lambert
May 31, 1996
Previous
1
2
…
1774
1775
1776
1777
1778
1779
1780
1781
1782
…
1788
1789
Next
RSS